Back
Verizon Communications Vs. Akero Therapeutics Industry Stock Comparison
Sell
27
VZ
Verizon Communications
Last Price:
39.49
Seasonality Move:
0.5%
Sell
28
AKRO
Akero Therapeutics
Last Price:
20.22
Seasonality Move:
16.15%
Sell
27
Verizon Communications (VZ)
is a Sell
Is Verizon Communications a Buy, Sell or Hold?
- The current Verizon Communications [VZ] share price is $39.70. The Score for VZ is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- VZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.00. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VZ Stock Price Chart
What is Verizon Communications's stock price today?
-
The Verizon Communications share price today is $39.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
VZ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 44.31 | Sell |
Chaikin Money Flow: | 13421682 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.73 - 41.87) | Sell |
Bollinger Bands (100): | (38.36 - 41.34) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.18 | Sell |
Relative Strength Index (14 RSI): | 35.31 | Sell |
Chaikin Money Flow: | 33831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.5 - 24.76) | Sell |
Bollinger Bands (100): | (19.91 - 26.11) | Sell |
VZ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.79 | Sell |
20-day SMA: | 40.91 | Sell |
50-day SMA: | 40.47 | Sell |
200-day SMA: | 36.82 | Buy |
8-day EMA: | 39.89 | Sell |
20-day EMA: | 40.36 | Sell |
50-day EMA: | 40.34 | Sell |
200-day EMA: | 38.55 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.3 | Sell |
20-day SMA: | 22.6 | Sell |
50-day SMA: | 24.68 | Sell |
200-day SMA: | 29.2 | Sell |
8-day EMA: | 21.33 | Sell |
20-day EMA: | 22.52 | Sell |
50-day EMA: | 23.52 | Sell |
200-day EMA: | 27.68 | Sell |
Verizon Communications Earnings Growth & VZ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.10 per share, and an increase next year of $0.12 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Verizon Communications Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |